| Secondary |
| Hypertension |
36.6% |
| Sepsis |
7.3% |
| Thrombosis Prophylaxis |
7.3% |
| Cholecystitis |
4.9% |
| Hyperparathyroidism Secondary |
4.9% |
| Hyperthyroidism |
4.9% |
| Prophylaxis |
4.9% |
| Sedation |
4.9% |
| Hypercholesterolaemia |
2.4% |
| Hypokalaemia |
2.4% |
| Obesity |
2.4% |
| Pancreatitis |
2.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.4% |
| Psychotic Disorder |
2.4% |
| Pulmonary Arterial Hypertension |
2.4% |
| Pyrexia |
2.4% |
| Renal Failure |
2.4% |
| Respiratory Disorder |
2.4% |
|
| Death |
22.2% |
| Drug Withdrawal Syndrome |
22.2% |
| Somnolence |
11.1% |
| Stevens-johnson Syndrome |
11.1% |
| Tooth Extraction |
11.1% |
| Toxic Epidermal Necrolysis |
11.1% |
| Weight Decreased |
11.1% |
|
| Concomitant |
| Hypertension |
26.9% |
| Product Used For Unknown Indication |
22.9% |
| Rheumatoid Arthritis |
5.1% |
| Pain |
4.9% |
| Prophylaxis |
4.9% |
| Drug Use For Unknown Indication |
4.3% |
| Atrial Fibrillation |
3.6% |
| Breast Cancer |
3.6% |
| Depression |
3.2% |
| Type 2 Diabetes Mellitus |
3.2% |
| Diabetes Mellitus |
2.6% |
| Lymphoma |
2.1% |
| Back Pain |
1.7% |
| Nausea |
1.7% |
| Thrombosis Prophylaxis |
1.7% |
| Coronary Artery Disease |
1.5% |
| Hepatic Neoplasm Malignant |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Hyperlipidaemia |
1.5% |
| Hyperparathyroidism Secondary |
1.5% |
|
| Vomiting |
14.7% |
| Red Blood Cell Sedimentation Rate Increased |
8.8% |
| Tremor |
8.8% |
| Weight Decreased |
8.8% |
| Pulmonary Embolism |
7.4% |
| Cerebrovascular Accident |
5.9% |
| Soft Tissue Infection |
4.4% |
| Stent Placement |
4.4% |
| Tachyarrhythmia |
4.4% |
| Anaemia Haemolytic Autoimmune |
2.9% |
| Atrial Fibrillation |
2.9% |
| Diarrhoea |
2.9% |
| Gastrointestinal Haemorrhage |
2.9% |
| General Physical Health Deterioration |
2.9% |
| Haemorrhage Subcutaneous |
2.9% |
| Hepatic Encephalopathy |
2.9% |
| Hypocalcaemia |
2.9% |
| Hypoglycaemic Seizure |
2.9% |
| Liver Function Test Abnormal |
2.9% |
| Loss Of Consciousness |
2.9% |
|
| Interacting |
| Analgesic Effect |
20.0% |
| Hyperlipidaemia |
20.0% |
| Hypertension |
20.0% |
| Platelet Aggregation Inhibition |
20.0% |
| Vitamin Supplementation |
20.0% |
|
|
